Originalbeitrag in Fachzeitschrift
Highly active engineered IgG3 antibodies against SARS-CoV-2
Kallolimath S, Sun L, Palt R, Stiasny K, Mayrhofer P, Gruber C, et al. Highly active engineered IgG3 antibodies against SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(42). doi:https://doi.org/10.1073/pnas.2107249118

- Citations
- Citation Indexes: 56
- Patent Family Citations: 2
- Captures
- Readers: 63
- Mentions
- News Mentions: 2
- Social Media
- Shares, Likes & Comments: 52
BOKU Autor*innen
Herta Steinkellner
Ao.Univ.-Prof.i.R. Mag.rer.nat.Dr.nat.techn. Herta Steinkellner
Benjamin Kogelmann
Dr. Benjamin Kogelmann M.Sc.
Roman Palt
Roman Palt M.Sc.
Somanath Kallolimath
Somanath Kallolimath M.Sc.Ph.D.
Lin Sun
Mag.Dr. Lin Sun